Business Context and Reporting Period
This Form 8-K Current Report was filed by Ares Commercial Real Estate Corporation (ACRE) on May 17, 2022, with the earliest event reported on the same date. The filing discloses the entry into a material definitive agreement regarding a public equity offering.
Key Financial Metrics
The filing details a capital raise event rather than periodic operating results. Key financial figures include:
- Shares Sold: 7,000,000 shares of common stock.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 1,050,000 shares.
- Net Proceeds: Approximately $103.1 million (after deducting estimated transaction expenses).
- Closing Date: May 20, 2022.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transaction-specific report.
Material Changes
The primary material change is the execution of an Underwriting Agreement with Morgan Stanley & Co. LLC, Wells Fargo Securities, LLC, Citigroup Global Markets Inc., and UBS Securities LLC as joint book-running managers. This transaction increases the company's equity capital base.
Guidance, Outlook, and Restrictions
Lock-Up Period: Pursuant to the Underwriting Agreement, the Company agreed not to sell or transfer any shares of its common stock or convertible securities for 30 days following May 20, 2022, without the written consent of the underwriters' representatives.
Legal and Tax Opinions: The filing includes opinions from Venable LLP regarding the legality of the shares and Kirkland & Ellis LLP regarding certain tax matters.
The filing text does not provide specific management commentary on future guidance, risks, or contingencies beyond the standard terms of the underwriting agreement.
Investor Verification Checklist
- Verify the final number of shares issued if the 1,050,000 share over-allotment option was exercised.
- Confirm the exact amount of transaction expenses deducted to arrive at the $103.1 million net proceeds.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification rights and termination provisions.
- Monitor the company's capital allocation strategy for the newly raised $103.1 million.